News Minimalist

All news ranked by significance

Study reveals GLP-1 drugs like Ozempic impact 175 health conditions including Alzheimer's and infections

nypost.com — January 21, 2025 at 06:01 PM UTC

A new study from the Department of Veterans Affairs analyzed medical records of 2.5 million patients and found that GLP-1 medications like Ozempic and Mounjaro affect 175 health conditions. This includes benefits for Alzheimer’s, substance abuse, and unexpected areas like blood clotting and infections. The study also indicated a reduced risk of psychotic disorders, seizures, and heart issues. While Ozempic is approved for Type 2 diabetes and obesity, Novo Nordisk plans to seek approval for chronic kidney disease treatment. However, some negative effects were noted, including gastrointestinal issues and an increased risk of arthritis. The study's findings may not fully represent the broader U.S. population due to the specific characteristics of the VA patient group.

With a significance score of 3.9, this news ranks in the top 11% of today's 18111 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 9000 minimalists.

Timeline:

[3.5]

Research highlights health effects of Ozempic and GLP-1 drugs (geneticliteracyproject.org)

46d 6h

[3.4]

Doctors discuss safety and long-term use of Ozempic for weight loss (today.com)

48d 18h

[3.8]

Study highlights risks of Ozempic and weight loss drugs for kidney and gastrointestinal health (timesofindia.indiatimes.com)

49d 22h

[3.7]

New study reveals benefits and risks of Ozempic and GLP-1 medications (foxnews.com)

50d 2h

[4.5]

Study reveals potential broader health benefits of GLP-1 medications beyond diabetes management (wmur.com)

50d 8h

[4.6]

Study finds GLP-1 medications may offer broader health benefits beyond diabetes management (kcra.com)

50d 8h

[4.5]

Study reveals broader health benefits and risks of GLP-1 medications beyond diabetes management (wcvb.com)

50d 8h

[4.1]

Ozempic and similar drugs may reduce risk of 42 health conditions but carry potential side effects (theconversation.com)

50d 15h

[4.0]

Study finds GLP-1 drugs like Ozempic may reduce heart attack and stroke risk while aiding weight loss (news.yahoo.com)

51d 1h

[4.5]

Study finds weight loss medications linked to lower dementia and heart risks (timesnownews.com)

51d 16h

[3.9]

Study reveals GLP-1 drugs like Ozempic impact 175 health conditions including Alzheimer's and infections (nypost.com)

51d 18h

[4.2]

Study finds weight-loss drugs like Ozempic may reduce risk of 42 health conditions in diabetes patients (forbes.com)

51d 22h

[5.0]

Study finds GLP-1 drugs may reduce Alzheimer's risk by 12% but raise safety concerns (news.yahoo.com)

51d 23h

[4.8]

Weight-loss drugs may lower risk of stroke and dementia, study finds (independent.co.uk)

52d 0h

[4.4]

Study finds weight-loss drugs like Ozempic may lower dementia risk but raise other health concerns (cbc.ca)

52d 2h

[4.3]

Obesity drugs show potential in reducing addictions according to new study (straitstimes.com)

52d 4h

[4.8]

New study reveals potential benefits and risks of Ozempic and similar drugs for health issues (sciencealert.com)

52d 6h

[3.1]

Study reveals weight loss injections reduce risk of 42 illnesses but increase chances of 19 others (thesun.co.uk)

52d 12h

[4.3]

Weight-loss injections may reduce risk of health issues, study finds (independent.co.uk)

52d 14h

[4.5]

Study highlights benefits and risks of popular weight-loss drugs in the US (news-medical.net)

52d 15h

[4.3]

Study finds Ozempic users have lower risk of heart attacks and strokes but face more gastrointestinal issues (theconversation.com)

52d 15h

[4.3]

Researchers map health effects of GLP-1 receptor agonists in new study (news-medical.net)

52d 17h

[4.8]

New weight-loss drugs show potential health benefits and risks, study finds (bbc.com)

52d 18h

[4.9]

GLP-1 drugs show more benefits than risks for approved uses in new analysis (newscientist.com)

52d 18h

[4.5]

Study finds weight-loss drugs may lower risk of 42 health conditions in diabetes patients (theguardian.com)

52d 18h

[4.5]

Study reveals potential new uses for GLP-1 medications beyond weight loss and diabetes (cnn.com)

52d 18h

[4.9]

Study reveals 60 health benefits and risks linked to Ozempic-style drugs (livescience.com)

52d 18h

[4.0]

Study links Ozempic use to potential organ damage risks (newsweek.com)

52d 19h